Kodiak Sciences Inc at Morgan Stanley Global Healthcare Conference Transcript
Great. Well, good afternoon, everybody. Thanks for joining us for the next session. I'm Matthew Harrison, one of the biotech analysts here at Morgan Stanley. Really pleased to have Kodiak with us. Quickly before we get started, I just need to read a disclosure statement.
So please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures.
So with that, pleased to have Victor Perlroth, who is the CEO of Kodiak with us. Victor, I thought maybe a good place to start is just in the last -- it is the last week.
Questions & Answers
It all blends together, but we got some -- we've got some data from Regeneron on high-dose. I think that just maybe a nice place to start is just how do you think about the competitive market at this point? There's been
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |